Camp4
CAMP4 Therapeutics - Pioneering a new class of RNA medicines to increase targeted gene expression
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- camp4tx.com
- Total Funding
- $100.0M
- Last Round
- $100.0M Series BJul 2022
- Rounds
- 1
About
CAMP4 Therapeutics is a clinical-stage biotech pioneering programmable RNA therapeutics for haploinsufficient diseases. Its regRNA platform combines gene regulation insights with computational biology to increase gene dosage in conditions where one functional gene copy is insufficient, targeting rare neurological and other genetic disorders.
Summary
Camp4 is a Healthcare company based in Cambridge, United States, founded in 2016. It has raised $100.0M in total across 1 round, most recently a $100.0M Series B round in Jul 2022. Investors include Patient Square Capital and Andreessen Horowitz.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Jul 2022
Investors
Similar Companies
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Biopharmaceutical services company